News
FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...
FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.
As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating ...
Get the latest federal technology news delivered to your inbox. The Food and Drug Administration launched an “aggressive timeline” on Thursday that charts its internal efforts to incorporate ...
In its yearly survey of international clinicians and patients, Philips illustrated significant gaps in people’s trust when it ...
The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...
Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...
The artificial intelligence (AI) revolution is reshaping our world at an unprecedented pace. As AI technology evolves, it's ...
The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, today announced its $365 million Series D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results